Literature DB >> 22536579

Pleural mesothelioma surveillance: validity of cases from a tumour registry.

France Labrèche1, Bruce W Case, Gaston Ostiguy, Jean Chalaoui, Michel Camus, Jack Siemiatycki.   

Abstract

BACKGROUND: Pleural mesothelioma is a rare tumour associated with exposure to asbestos fibres. Fewer than than one-quarter of cases registered in the Quebec Tumour Registry (QTR) have been compensated as work-related. While establishing a surveillance system, this led to questioning as to whether there has been over-registration of cases that are not authentic pleural mesotheliomas in the QTR.
OBJECTIVE: To assess whether registered cases of pleural mesothelioma could be confirmed.
METHODS: A medical chart review was designed to assess the proportion of mesothelioma cases newly registered in the QTR in 2001⁄2002 that could be confirmed. For each registered case, clinical, medical imaging and pathology information were sought and, occasionally, additional immunohistochemistry staining was obtained. Three specialists - a chest physician, a radiologist and a pathologist - reviewed the available information and material, coding each mesothelioma case as to degree of certainty of the mesothelioma diagnosis.
RESULTS: The QTR reported 190 incident cases of mesothelioma (81% males) for the period. The specialists classified 81% of charts as 'certain⁄probable' or 'possible' mesotheliomas, 8% as 'unlikely to be a mesothelioma' and 11% as 'not a mesothelioma'. After excluding chart summaries of unsatisfactory quality, 87% to 88% of the charts were classified as 'certain⁄probable' or 'possible' mesotheliomas, and 9% to 11% were still considered 'not a mesothelioma'.
CONCLUSION: Tumour registry data are a valid source of information for mesothelioma surveillance. While there is some over-registration of mesothelioma cases in the QTR, a significant majority of registered cases appeared to be authentic. Over-registration cannot explain the greater proportion of cases that were not compensated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22536579      PMCID: PMC3373292          DOI: 10.1155/2012/650935

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  18 in total

1.  Surveillance of mesothelioma and workers' compensation in British Columbia, Canada.

Authors:  Tracy L Kirkham; Mieke W Koehoorn; Christopher B McLeod; Paul A Demers
Journal:  Occup Environ Med       Date:  2010-09-27       Impact factor: 4.402

2.  BTS statement on malignant mesothelioma in the UK, 2007.

Authors: 
Journal:  Thorax       Date:  2007-11       Impact factor: 9.139

3.  [Comparison of the French DRG based information system (PMSI) with the National Mesothelioma Surveillance Program database].

Authors:  B Geoffroy-Perez; E Imbernon; A Gilg Soit Ilg; M Goldberg
Journal:  Rev Epidemiol Sante Publique       Date:  2006-12       Impact factor: 1.019

4.  French mesothelioma register.

Authors:  J Bignon; P Sebastien; L Di Menza; H Payan
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

5.  The Australian Mesothelioma Surveillance Program 1979-1985.

Authors:  D A Ferguson; G Berry; T Jelihovsky; S B Andreas; A J Rogers; S C Fung; A Grimwood; R Thompson
Journal:  Med J Aust       Date:  1987-08-17       Impact factor: 7.738

6.  Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends.

Authors:  Fabio Montanaro; Freddie Bray; Valerio Gennaro; Enzo Merler; Jerzy E Tyczynski; Donald Maxwell Parkin; Marija Strnad; Marie Jechov'a; Hans H Storm; Tiiu Aareleid; Timo Hakulinen; Michel Velten; Hacina Lef'evre; Arlette Danzon; Antoine Buemi; Jean-Pierre Daur'es; François Ménégoz; Nicole Raverdy; Martine Sauvage; Hartwig Ziegler; Harry Comber; Eugenio Paci; Marina Vercelli; Vincenzo De Lisi; Rosario Tumino; Roberto Zanetti; Franco Berrino; Giorgio Stanta; Frøydis Langmark; Jadwiga Rachtan; Ryszard Mezyk; Jerzy Blaszczyk; Plesko Ivan; Maja Primic-Zakelj; Alvaro Cañada Martínez; Isabel Izarzugaza; Joan Borràs; Carmen Martínez Garcia; Isabel Garau; Navarro Carmen Sánchez; Ardanaz Aicua; Lotti Barlow; Joachim Torhorst; Christine Bouchardy; Fabio Levi; Thomas Fisch; Nicole Probst; Otto Visser; Mike Quinn; Anna Gavin; David Brewster; Marica Mikov
Journal:  Cancer Causes Control       Date:  2003-10       Impact factor: 2.506

7.  Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.

Authors:  Aliya N Husain; Thomas V Colby; Nelson G Ordóñez; Thomas Krausz; Alain Borczuk; Philip T Cagle; Lucian R Chirieac; Andrew Churg; Francoise Galateau-Salle; Allen R Gibbs; Allen M Gown; Samuel P Hammar; Leslie A Litzky; Victor L Roggli; William D Travis; Mark R Wick
Journal:  Arch Pathol Lab Med       Date:  2009-08       Impact factor: 5.534

Review 8.  Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005.

Authors:  Bertram Price; Adam Ware
Journal:  Crit Rev Toxicol       Date:  2009       Impact factor: 5.635

9.  Under-reporting of compensable mesothelioma in Alberta.

Authors:  Marilyn W Cree; Munira Lalji; Bei Jiang; Keumhee C Carriere
Journal:  Am J Ind Med       Date:  2009-07       Impact factor: 2.214

10.  Malignant mesothelioma of the pleura: interobserver variability.

Authors:  A Andrion; C Magnani; P G Betta; A Donna; F Mollo; M Scelsi; P Bernardi; M Botta; B Terracini
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.